Trials / Conditions / Metastatic Malignant Neoplasm in the Leptomeninges

Metastatic Malignant Neoplasm in the Leptomeninges

7 registered clinical trials studyying Metastatic Malignant Neoplasm in the Leptomeninges — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non- NCT06910761	City of Hope Medical Center	Phase 2
Recruiting	Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis NCT06500481	NRG Oncology	Phase 3
Recruiting	Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast C NCT06518057	University of Washington	Phase 2
Withdrawn	Trotabresib in Combination With Vinorelbine and Radiation Therapy for the Treatment of HER2+ Breast Cancer Wit NCT06137651	Northwestern University	Phase 1
Recruiting	Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or L NCT05746325	Mayo Clinic	N/A
Active Not Recruiting	Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Eso NCT04460937	National Cancer Institute (NCI)	Phase 1
Active Not Recruiting	HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases NCT03696030	City of Hope Medical Center	Phase 1